Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7413156
Reference Type
Journal Article
Title
Fate and Effects of Cytostatic Pharmaceuticals in the Marine Environment
Author(s)
Bebianno, MJ; Garcia da Fonseca, T; ,
Year
2020
Is Peer Reviewed?
1
Journal
Marine Pollution Bulletin
ISSN:
0025-326X
EISSN:
1879-3363
Publisher
Springer International Publishing
Location
Cham
Book Title
Fate and Effects of Anticancer Drugs in the Environment
Page Numbers
295-330
PMID
32736201
DOI
10.1007/978-3-030-21048-9_13
Web of Science Id
WOS:000568702500017
URL
http://link.springer.com/10.1007/978-3-030-21048-9_13
Exit
Abstract
The consumption of anticancer agents has increased in the recent decades, and these substances may be present in sewage. Consequently, they may reach the environment when sanitation infrastructure is ineffective. This study evaluated the toxicity of three anticancer agents-Tamoxifen (TAM), Cisplatin (CisPt), and Cyclophosphamide (CP)-on the development of embryos of the sand-dollar Mellita quinquiesperforata. Adult individuals were collected in sandy beaches, and gametes were obtained. Freshly-fertilized eggs were exposed to increasing sets of concentrations of each compound, and the effective concentrations needed to cause a 50% effect in the organisms (EC50) were calculated. The three compounds were toxic, and their EC50 values were 16.78 +/- 2.42 ng.L-1 (TAM), 27.20 +/- 38.26 ng.L-1 (CisPt), and 101.82 +/- 70.96 ng.L-1 (CP). There is no information on the environmental levels of these compounds in Brazil, but as they were already detected in ng.L-1 levels worldwide, it can be expected that these substances pose environmental risks to the marine biota.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity